Centogene
Dr. Marc Steder currently serves as Vice Director of Pharma Project Management at CENTOGENE, overseeing the successful management of multiple pharma-related projects and ensuring operational efficiency in the delivery of diagnostic laboratory services. Previously, Dr. Steder held positions as a Senior Operational Project Specialist and Operational Project Specialist, focusing on the execution of complex pharma projects and facilitating cross-functional team support. Prior to the pharma sector, Dr. Steder operated as a Digital Project Manager and Web Developer, delivering web and e-commerce solutions to clients. Dr. Steder's academic background includes a PhD in Molecular Biology and a Diplom in Biochemistry and Molecular Biology from Universität Rostock, along with research experience in cancer biology, specifically malignant melanoma metastasis.
This person is not in any teams
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.